ACE2 was homogenously expressed in primary tumor samples from CRC-Liver group, while CLDN18 and DUSP4 were homogenously expressed in Peritoneum samples with a Log2 fold change of −3.267, 4.891 and 2.764 respectively (Supplementary Table S1). The gene discussed is ACE2; the disease is colorectal carcinoma.